A Study of Tobacco Smoke and Children With Respiratory Illnesses
Urine Cotinine in Children and Parental Behavior Modification: A Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maine
-
Portland, Maine, United States, 04101
- The Barbara Bush Children's Hospital at Maine Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 0 to 10 years old
- admitted to The Barbara Bush Children Hospital for bronchiolitis, pneumonia, bronchopulmonary dysplasia, or asthma
- the child lives with an adult who smokes cigarettes
Exclusion Criteria:
- Non-English-speaking and -reading adults will be excluded as our interventions are in English.
- Children over the age of 10 will be excluded as we wanted to avoid children who themselves smoke, given that we will not have a confidential way to assess this.
- Breastfeeding children will be excluded as nicotine is transferrable in breast milk.
- Families (meaning the parent or guardian, the child, and any smoking coinhabiting caregiver) will be excluded if the parent or the smoking adult is a minor, as they would not be able to give consent for participation.
- Children in foster care or whose guardian is the state will be excluded as we are unlikely to achieve timely consent.
- Families who do not reside in Maine will be excluded as The Maine Tobacco Helpline is not able to provide services for out-of-state residents.
- Children readmitted to the hospital during our study period will be excluded if they have already participated in this study during a previous admission.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: All Participants
Breathe Easy Coalition written materials provided to parent/guardian, plus Maine Tobacco Helpline referral provided to smoking adult in the home, plus testing of the child's urine cotinine and results reported to parent/guardian
|
written materials about secondhand and thirdhand environmental smoke exposure in children
referral to tobacco cessation counselor, helpline calls adult referred to provide counseling over the phone.
the child's urine is tested for cotinine, which is produced when the body absorbs nicotine.
These results are communicated to the child's parent/guardian.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of acceptance of a smoking cessation intervention
Time Frame: one month for each patient
|
Rate of acceptance of participation in each of the three smoking cessation interventions in this patient population at BBCH--written materials, phone counseling, and urine cotinine testing.
|
one month for each patient
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of positive urine cotinine in children admitted with positive tobacco smoke exposure history.
Time Frame: 24 hours for each patient
|
We will assess the number of children who have a positive smoke exposure history and whose urine is positive for cotinine.
|
24 hours for each patient
|
|
Staff hours required to provide a smoking cessation intervention
Time Frame: one month for each patient
|
The staff hours required to provide timely consent and sample collection, and the staff hours required to collect data and provide test results
|
one month for each patient
|
|
Rate of acceptance of follow-up urine cotinine testing
Time Frame: one month for each patient
|
Rate of parental acceptance of possible follow-up cotinine testing were it provided in a future study.
|
one month for each patient
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Deirdre Burns, MD, MPH, MaineHealth
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 986404-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.